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Summary 
Dendritic cells (DC) are described as "nature's adjuvant," since they have the capacity to sensi- 
tize T  cells in vivo upon first encounter with the antigen. The potent accessory properties of 
DC appear to develop sequentially. In particular, the ability to process antigens and to sensitize 
naive T  cells  develops in sequence, a  process termed "maturation" that is well described in 
vitro. Here, we obtain evidence for maturation in vivo in response to the bacterial product li- 
popolysaccharide (LPS). Before LPS treatment, many DC are found at the margin between the 
red and white pulp. These cells lack the M342 and DEC-205 markers, but process soluble pro- 
teins effectively. 6  h  after LPS, DC  with the M342  and DEC-205  markers are found in in- 
creased numbers in the T  cell areas. These cells have a reduced capacity to process proteins, but 
show increases in the B7 costimulator and T  cell stimulatory capacity. 48 h after LPS, the num- 
ber of  DC in the spleen is reduced markedly. We interpret these findings to mean that LPS can 
cause DC in the marginal zone to mature and to migrate into and then out of the T  cell areas. 
O 
Ptimal activation of T  lymphocytes depends on TCR 
interactions with peptide/MHC  complexes in  con- 
junction with costimulatory signals that are typically deliv- 
ered by the same APC. The costimulatory signal is antigen 
nonspecific, and is delivered by CD28 or CTLA4 on T  cells 
that interact with a ligand, B7-1  (CD80) or B7-2 (CD86), 
that is present on the APC  (1). The role of costimulatory 
molecules has been clearly demonstrated by studies show- 
ing that antigenic stimulation of T  cells in vitro in the ab- 
sence of costimulation leads  to aborted T  cell proliferation 
and  the  development  of functional  unresponsiveness  or 
clonal anergy of T  cells  (2). Injection of CTLA4Ig, a solu- 
ble form of the extracellular domain of CTLA-4 with high 
avidity for B7-1 and B7-2, suppresses T  cell-dependent anti- 
body  responses  in  vivo  (3).  CTLA4Ig  is  also  capable  of 
blocking in vitro proliferation in assays ofalloreactivity (4, 5), 
as well as preventing xenograft rejection (6) and prolonging 
allograft rejection (7,  8).  These data show that B7/CD28- 
CTLA4 activation pathways play an important role in reg- 
ulating in vivo T  cell responses. 
Among  the  population  of APC,  which  in  the  mouse 
comprises dendritic cells  (DC) ~, B lymphocytes, and mac- 
rophages, DC  appear to have the unique capacity to acti- 
1Abbreviations used in this paper: BR, blocking  reagent; DC, dendritic  cells; 
SEB, staphylococcal  enterotoxin  B. 
vate naive T  cells (9). In vitro, they are essential  to trigger a 
primary  antibody response  (10)  and  to  generate  antiviral 
CTL (11,  12),  and they strongly stimulate CD4 + (13) and 
CD8 + (14)  cells in the primary mixed leukocyte reaction. 
In vivo, DC appear to play a major role in initiating various 
T  cell immune responses,  such as contact sensitivity (15-17) 
and allograft rejection (18-21). DC pulsed extracorporeally 
can  efficiently induce  cellular  (22)  and  T  cell-dependent 
humoral  (23,  24)  responses in mice.  The property of iso- 
lated DC  to sensitize quiescent T  cells  upon the first  en- 
counter with the antigen correlates with their capacity to 
express very high levels of antigen/MHC peptides, as well 
as B7-1 and B7-2 costimulatory molecules (5, 25, 26). 
The first step of  the immune response leading to efficient 
activation  of antigen-specific,  naive  T  cells  in  situ  is  still 
poorly understood. DC are likely to be the adjuvant of the 
immune system in vivo. DC are motile and efficiently clus- 
ter T  cells,  are widely distributed in tissues,  carry antigens 
that  are  administered  intradermally or intravenously,  and 
circulate  through  lymph  or  blood  probably  in  route  to 
lymphoid organs (for review see reference 9).  The analysis 
of cryostat sections (26),  however, revealed that B7-1  and 
B7-2 staining was weak or negative in most nonlymphoid 
organs, but strong in select sites in lymphoid organs. In par- 
ticular,  in  the spleen,  both MHC  class II  and B7-2 were 
expressed strongly on  dendritic profiles in  the  T  cell re- 
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Volume 184  October 1996 1413-1424 gions that occupy the center of the white pulp, but not in 
marginal zone where DC are abundant, and they carry high 
levels of the  CDllc  leukocyte integrin.  Furthermore,  the 
expression of both B7  molecules is weak  on DC  that  are 
freshly isolated from the spleen, but is strongly upregulated 
in vitro, without intentional stimulation (26, 27). This pro- 
cess  of maturation is  characterized by the  upregulation  of 
the  T  cell-sensitizing function  and the  downregulation  of 
the  antigen-processing capacity during  short-term  culture 
(26-30).  These  observations indicate that DC  do  not  dis- 
play constitutive costimulatory function in situ, and suggest 
that they may mature into potent accessory cells during the 
early sensitization phase of immunity. 
In  this paper,  we  show  that  systemic  administration of 
endotoxin (LPS) induces the migration of most splenic DC 
from  the marginal zone  to  the  T  cell areas within  4-6  h. 
This  movement  parallels a  maturation  process,  as  assessed 
by downregulation of processing capacity and upregulation 
ofimmunostimulatory properties. Unexpectedly, 48 h  after 
LPS injection, the number of splenic DC  decreased mark- 
edly, an observation that correlates with an impaired capac- 
ity to activate naive T  lymphocytes in vitro and in vivo. 
These data show that DC function is regulated by micro- 
bial products. LPS induces DC  migration and maturation in 
vivo, resulting in colocalization of potent DC and T  lym- 
phocytes. The  subsequent loss of DC  after activation may 
be part of a negative feedback mechanism that controls in vivo 
inflammatory responses that may cause severe tissue damage. 
Materials  and Methods 
Mice 
Female BALB/c (H-2  d) and CBA/J (H-2k), 6-8-wk old, were 
purchased  from  Charles  P,  iver  Wiga  (Sulzfeld,  Germany)  and 
maintained in our own pathogen-free facility. 
Reagents and Antibodies 
LPS from Escherichia coli (serotype 055:B5)  was purchased from 
Difco Laboratories (Detroit, MI). Purified exotoxin staphylococ- 
cal enterotoxin B  (SEB) was purchased from Toxin Technology, 
Inc.  (Sarasota, FL). Hamster mAb 37.51 to murine CD28 and con- 
trol mAb F531  (kindly provided by J. Allison, University of Cali- 
fornia, Berkeley, CA; 31) were used at 1/10,000 dilution of ascitic 
fluids. Hamster mAb 145-2Cll to mouse CD3e (32) was purified 
in our laboratory.  Myoglobin from sperm whale skeletal muscle was 
obtained from Fluka Chemie AG (Buchs,  Switzerland). Pork in- 
sulin was purchased from Sigma Immunochemicals (St. Louis, MO). 
In  Vivo Treatment 
Endotoxinlnjection.  BALB/c  mice  were  injected  intrave- 
nously into the lateral tail vein with 25  p,g LPS solubilized in 
pyrogen-free NaCI 0.9%.  Control animals were injected with the 
same volume of NaC1. 
T Cell Activation In Vivo.  LPS-treated  and  control  BALB/c 
mice were injected with either 50  t*g SEB or 50  txg anti-CD3e 
solubilized in pyrogen-free NaC1 0.9%.  The mice were bled 2 h 
later, and the sera were assayed for IL-2 content using a standard 
bioassay using an  IL-2-dependent, IL-4-insensitive subclone of 
the CTL.L line. IFN-~/was quantitated by two-site ELISA using 
mAbs F1  and Db-1, kindly provided by Dr. Billiau (Katholieke 
Universiteit Leuven, Leuven, Belgium) and P,H. Van Der Meide 
(TNO  Health  Research,  P,  ijswijk,  The  Netherlands),  respec- 
tively. 
Cell Lines 
The I-Ea-restricted, myoglobin-specific T  cell hybridoma 13- 
26-8-HG.1  (33) was  kindly  provided  by  Dr.  A.  Livingstone 
(Basel  Institute of Immunology, Basel, Switzerland). The  I-E  a- 
restricted, pork insulin-specific T  cell hybridoma B8P4.] C3 (34) 
was kindly provided by Dr T. Delovitch (John  P. Robarts Re- 
search Institute, London, Ontario, Canada). 
Flow Cytometry 
Cells were analyzed by flow cytometry with a FACScan  |  cy- 
tometer  (Becton Dickinson &  Co., Mountain View,  CA). The 
cells were preincubated or not (see figure legends) with 2.4G2 (a 
rat anti-mouse Fc receptor mAb) for  10  rain before staining to 
prevent antibody binding to FcR., and were incubated with fluo- 
rescein-coupled mAb  14.4.4  (murine lgG2a anti-I-E  a,  available 
through  American  Type  Culture  Collection,  R.ockville, MD), 
N418  (hamster antimurine CDllc;  35),  1610A1  (hamster anti- 
B7-1;  36),  GL1  (rat  IgG2a  anti-B7-2;  37)  with  PE-coupled 
CD45K/B220  (rat IgG2a; PharMingen, San Diego, CA) or with 
biotinylated N418 followed by avidin coupled to PE or with bio- 
tinylated CDI 1b/Mac1 (PharMingen) revealed by avidin coupled 
to fluorescein. Cells were gated according to size and scatter to 
eliminate dead cells and debris from analysis. 
Purification of Low Density Spleen Cells 
and Fresh DC 
Spleens were digested with collagenase (CLSIII; Worthington 
Biochemical Corp.,  Freehold,  NJ)  and  separated into  low  and 
high density fractions on a BSA gradient (Bovuminar Cohn frac- 
tion V  powder; Armour Pharmaceutical Co.,  Tarrytown, NY), 
according to a procedure described by Crowley et al. (38). A fur- 
ther purification of fresh DC (without in vitro culture) by enrich- 
ment on a Mini Macs column was sometimes performed, accord- 
ing  to  the  manufacturer's  recommendations  (Miltenyi  Biotec 
GmbH, Bergisch-Gladbach, Germany). In brief, low density spleen 
cells were incubated with biotinylated N418, washed, and incu- 
bated with  streptavidin microbeads.  Cells were  then  positively 
enriched on a Mini Macs column. More than 85% of these cells 
expressed N418  and MHC  class II. For FACS  |  analysis,  a  gate 
was performed on N418-positive cells. 
Figure 1.  LPS induces migration of N418-positive cells  from the marginal zone of the spleen to the T cell area. Inmmnoperoxidase labeling ofcryostat 
sections from spleens of control mice (A-D) and mice treated 6 h (E-H) or 48 h (I-L) previously with 25 Ixg LPS intravenously. Sections were stained 
with anti-CD1 lc mAb (/1, E, and/), with anti-DEC-205 mAb (B, F, and/), with M342 mAb (C, G, and K), or with anti-CD4 mAb (D, H, and L). The 
sections stained with anti-CDllc and anti-CD4 mAb were counterstained with hematoxylin; the sections stained with NLDC-145  and M342 were 
counterstained with methyl green. The oriNnal magnilqcation  was 10. V, white pulp; *, red pulp; --% marginal zone. 
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Figure 2.  Splenic  DC upregulate 
MHC  class II  and  B7  expression 
early after LPS injection. N418-pos- 
itive cells enriched from low density 
spleen cells from BALB/c mice in- 
jected with NaC1 or LPS 6 h earlier 
were double stained for red fluores- 
cence with biotinylated anti-CD11c 
mAb  followed  by  streptavidin-PE 
and  for  green  fluorescence with 
anti-l-E  d,  anti-B7-1,  or  anti-B7-2 
mAbs coupled  to  fluorescein. The 
DC-enriched population (see Mate- 
rials and Methods) contained at least 
85% CD11c-positive cells. The data 
represent  the  expression of MHC 
class II,  B7-1,  and  B7-2  on  cells 
gated for CD1 lc expression. 
In  Vitro Responses 
The  complete  medium  used  in  all  experiments was  R.PMI 
1640  (Seromed Biochem KG,  Berlin,  Germany)  supplemented 
with  2%  HY  ultroser  (a  serum-free  medium  supplement  pur- 
chased from  GIBCO BILL,  Merelbeke, Belgium)  or  10%  FCS, 
penicillin, streptomycin, nonessential aminoacids, sodium pyru- 
vate,  2-ME,  and  L-glutamine  (Flow  ICN  Biomedicals, Bucks, 
UK). Splenic T  cells were purified by depletion of adherent cells 
by passage  over Sephadex G10  (Pharmacia Bioprocess, Uppsala, 
Sweden) and complement mediated lysis with a cocktail of anti- 
APC  antibodies.  T  cells  were  stimulated with  graded doses  of 
SEB  in the presence of ~/-irradiated (3,000  rads)  spleen cells  or 
fresh DC in round-bottom 96-well plates, or were cultured in the 
presence of various numbers of'y-irradiated (3,000  rads)  alloge- 
neic spleen cells. Cultures were maintained at 37~  in a humidi- 
fied incubator (7% CO2).  The supernatants were  collected after 
12-48  h  of culture,  frozen,  and  assayed  for  IL-2  content  (see 
above). 
Immunohistochemistry 
Tissues samples were frozen in isopentane and 12-1~m cryostat 
sections were prepared. Samples were fixed in neat acetone for 10 
min, air-dried, and incubated in PBS containing 0.5% of  blocking 
reagent (BR)  from Boehringer for 30 min.  Sections were incu- 
bated for 20 min with culture supematant of the monoclonal rat 
anti-mouse antibody 2.4G2  to  Fc receptors to prevent nonspe- 
cific staining, except when culture supematants were used for pri- 
mary antibodies. Slides were washed in PBS, incubated for 1 h at 
room temperature with 10 I~g/ml in PBS-BR 0.5 % biotinylated 
mAbs (N418, anti-CDllc, and anti-mouse-CD4 [PharMingen]) 
or with culture supernatants from rat NLDC-145,  (also termed 
anti-DEC-205 [39; kindly provided by Dr. J. Austyn, University 
of Oxford, UK] or hamster M342 [40; kindly provided by Dr. R.. 
Steinman, The Kockefeller University, New York] and washed 
in PBS. Slides were then incubated in a 1:100  dilution of avidin- 
biotin-peroxidase complex (Vectastain ABC kit; Vector Labora- 
tories, Inc., Burlingame,  CA) in PBS-BR  0.5%  or goat F(ab')2 
anti-rat Ig-peroxidase (POD)  (BioSource  International, Cama- 
rillo, CA) or rabbit F(ab')2 anti-hamster Ig-POD (Rockland Inc., 
Gilbertsville, PA) for 30 min and washed in PBS. The peroxidase 
activity was  revealed with  a  solution of diaminobenzidine tet- 
rahydrochloride with  or without metal enhancer  (DAB tablets, 
SigrnaFAST; Sigma). The sections were stained for 10 min at room 
temperature, counterstained with hematoxylin or methyl green, 
and mounted with Poly-mount (Polysciences Inc., Warrington, PA). 
Results 
LPS Induces Migration of N418-positive  Cells fiom the Mar- 
ginal Zone of the Spleen to the T  Cell Area.  LPS  was  admin- 
istered to mice, and DC and T  cells were visualized in serial 
cryosections from  spleens  6  and  48  h  later using  specific 
mAbs  (Fig.  1).  Two  populations of DC  were  detected in 
the spleens of untreated mice (left panel),  as described previ- 
ously (35, 39,  40). The majority of N418-positive cells (A) 
were detected in the marginal zone between red and white 
pulp, whereas a few cells were labeled in the T  cell area (D) 
in the white pulp. Staining with NLDC-145  (B) and M342 
(C) antibodies outlined some positive cells only in the T  cell 
area. 
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Figure  3.  LPS  induces  func- 
tional maturation of splenic DC 
within a few hours. N418-posi- 
rive cells enriched from low den- 
sity spleen cells from BALB/c 
mice injected with NaC1 (circles) 
or LPS 6 h earlier (squares)  were 
cultured with (A) 2 ￿  105 synge- 
neic T cells in the presence of se- 
rial dilutions of SEB or (B) with 
5  ￿  104  T  cell  hybridoma 
B8P4.1 C3 and 200  Ixg/rnl pork 
insulin.  IL-2  production  was 
quantitated from the 12-h (A) or 
24-h (B) culture supernatants. 
The  injection  of LPS  leads  to  a  redistribution  of DC 
markers in  the  spleen,  suggesting that  DC  have migrated 
from the  marginal zone  to  the  T  cell area.  Fig.  1  (middle 
panel) shows serial sections stained with various antibodies. 
Most N418-positive  (E)  cells  were detected in association 
with T  cells  (H) 6  h  after injection of LPS. Adjacent sec- 
tions of the T  cell areas were strongly stained with NLDC- 
145 (F) and M342  (G) antibodies. 48 h after endotoxin ad- 
ministration  (Fig.  1,  right  panel),  the  overall  number  of 
splenic DC was strongly reduced, since only few cells in the 
T  cell areas  (L) stained with N418  (/),  NLDC-145  (J), or 
M342  (K). 
Splenic DC  Upregulate  MHC  Class  II and B7 Expression 
Early after LPS Injection.  Since the expression of M342  and 
NLDC-145  is weak or absent on freshly isolated DC and 
increased after culture and maturation in vitro (40,  41), we 
tested whether LPS could induce DC maturation in vivo. 
LPS was injected intravenously, and 6 h  later, low density 
spleen  cells  were  enriched  for N418 +  cells  (see  Materials 
and Methods), and the expression of MHC class II and co- 
stimulatory  molecules  (B7.1  and  B7.2)  was  analyzed  by 
FACS  |  As shown in Fig. 2, DC isolated from LPS-treated 
mice  displayed  increased  levels  of I-E,  B7-1,  and  B7-2 
molecules, as compared to control animals, whereas the ex- 
pression of CDllc remained unchanged. 
LPS Induces  Functional Maturation  of Splenic DC  within  a 
Few Hours.  One  of the  hallmarks  of maturation  of DC 
upon  culture  in  vitro is  an increased  capacity to  sensitize 
naive T  cells and a reciprocal downregulation of the capac- 
ity to process protein antigens (26-30). To test whether the 
injection of LPS and the subsequent upregulation of MHC 
class II and costimulatory molecules on DC were associated 
with a functional maturation in vivo, splenic DC were pu- 
rified from naive or LPS-injected animals and immediately 
tested as accessory cells for the presentation of SEB to syn- 
geneic  naive  T  cells.  This  superantigen  does  not  require 
processing and is best presented by DC (42,  43). As shown 
in Fig.  3 A, DC enriched from animals that had been in- 
jected with LPS 6 h  earlier were better activators ofT cells 
than DC from untreated animals. The increased immuno- 
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stimulatory properties of DC from LPS-treated mice were 
inversely  correlated  with  their  capacity  to  process  and 
present a protein antigen, as assessed by a decreased ability 
to present insulin to T  cell hybridoma (Fig.  3  B).  The ca- 
pacity of DC to present antigens that do not need process- 
ing  (SEB  or peptides)  to  T  cell hybridoma remained un- 
changed 6 h after endotoxin administration (data not shown). 
LPS Injection  Results in the Loss of N418-positive  Cells fiom 
Mouse Spleen after 2 d.  The  staining  of  spleen  cryosec- 
tions  (Fig.  1)  revealed that the movement of DC induced 
early by LPS was followed by a strong reduction ofN418 + 
cells 48 h  later.  To further document this observation and 
to  analyze whether  the  loss  of N418  staining in  cryosec- 
tions corresponded to the absence of DC or to a selective 
loss  of N418  marker, we performed immunofluorescence 
studies  on  DC-enriched,  low-density  spleen  cells.  Fig.  4 
represents the contour profiles of cells double-stained with 
B220  in  red,  and  either  N418  or  14-4-4  (anti-I-E  d)  in 
green.  The  data  show  that  low  density  spleen  cells  from 
LPS-injected  mice  lack  the  DC  population  identified  as 
B220-,  14-4-4big h, or B220-, N418 +. The numbers of DC 
returned to control levels 15 d after endotoxin administra- 
tion. The APC populations were further stained in unsepa- 
rated spleens. As shown in Table 1, LPS-injected mice had 
reduced numbers of DC,  as compared to control animals. 
By  contrast,  the  numbers  of B  lyrnphocytes  and  macro- 
phages were increased in treated animals.  Taken together, 
these data strongly suggest that a single injection of LPS re- 
suits in a selective loss of a major population of splenic DC. 
LPS Administration  Results  in Decreased  Capacity  to  Sensi- 
tize Naive T Lymphocytes In Vitro 2 d after Injeca'on.  Since  DC 
appear to have the unique property to activate naive T  cells 
in vitro, we tested the capacity of splenic cells from control 
and LPS-injected (2 d  earlier) mice to induce primary im- 
mune responses in vitro.  Irradiated spleen cells from LPS- 
injected animals induced lower IL-2 secretion (Fig.  5 A) by 
naive,  allogeneic  T  cells  than  spleen  cells  from  control 
mice. Equal numbers of spleen cells from control and LPS- 
treated mice stimulated T  cells at intermediate levels, sug- 
gesting that no mechanism of suppression was induced after control  LPS 2 days  LPS  15 days 
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Figure 4.  LPS injection results in the loss of N418-positive cells from mouse spleen  after 2 d. Two-color immunofluorescence  analysis  contour plots. 
Spleen cells from the low buoyant density  fraction were stained for red fluorescence  with PE anti-B220 nLAb  and for green fluorescence  with anti-l-E  d 
or anti-CDl lc mAb coupled to FITC. Cells were from a pool of two BALB/c mice and injected 48 b or 15 d previously  with NaCI (control) or 25 txg 
LPS. Boxes on the contour plots define selected populations.  DC were identified  as B220/CD45R.-, I-E  a+ or B220/CD45R-,  CD1 lc +, 
LPS injection. Similar data were obtained when syngeneic 
T  lymphocytes were stimulated by SEB in the presence of 
irradiated spleen cells from both groups (Fig.  5  B).  By con- 
trast, spleen cells from control and endotoxin-injected  mice 
induced  similar  IL-2  production  by  CD28-independent 
T  cell hybridoma, which has been shown to respond opti- 
mally to T  cell receptor ligation in the absence of B7-related 
costimulatory function (Fig. 5 C). The addition of antibod- 
ies specific for CD28  overcame the APC  defect of spleen 
ceils from LPS-injected mice in the MLP,. (Fig. 5 D), sug- 
gesting that  spleen cells from treated  animals retained the 
ability to  generate a  TCR  ligand, but displayed defective 
costimulatory function. 
Injection of LPS Results in Impaired DC Function In  Vivo af- 
ter 48 h.  We  next  compared  the  in  vivo  immune  re- 
sponse of control and LPS-treated mice after injection of 
DC-dependent or -independent stimuli. Control and LPS- 
treated mice were injected with 50 Ixg SEB or with 25 Izg 
anti-CD3 mAb (mainly presented by FcR. + B cells or mac- 
rophages; 44), and were bled 2 h  later to quantify the IL-2 
and the IFN-y produced in the sera.  Fig. 6 shows that the 
injection of the T  cell mitogen anti-CD3 mAb resulted in 
high  production of IL-2  and  IFN-y in  both  groups.  By 
contrast, the secretion of IL-2 and IFN-y after stimulation 
by SEB  was reduced in mice injected with endotoxin, as 
compared to untreated animals. 
Discussion 
The unique capacity of splenic DC to optimally activate 
naive T  cells  has  been  extensively demonstrated in vitro 
Table  1.  Effect  of LPS on Splenic Cell Populations 
Control*  LPS 
DC  at  0.84~  0.20 
B cells  39.l)  49.0 
Macrophages  3.3  5.5 
*The numbers of spleen cells were: 9 ￿  107 (control); 1.4 ￿  108 (LPS- 
injected 48 h earlier). 
:~Splenic cell populations were identified as  follows: DC,  CDllc +, 
14.4.4+;  B  lymphocytes, CD45R/B220+;  macrophages, CD45FZ/ 
B220-, CD11  b/Mac-I ~+. 
~Percent of splenic cells. 
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Figure 5.  LPS administration results in decreased 
capacity to sensitize naive T lymphocytes in vitro 
2 d after injection. (A) Various numbers of ~/-irra- 
diated (3,000 rads) spleen cells from control (circles) 
or LPS-injected (squares)  BALB/c mice or both (tr/- 
angles)  were cultured with 3 X 105 T cells  from CBA 
mice.  IL-2  production  was  quantitated from  the 
48-h  culture supernatants. (B) "y-Irradiated spleen 
cells from control (squares)  or LPS-injected (trian- 
gles)  mice were cultured with 2 ￿  105 syngeneic T 
cells in the presence of serial dilutions of SEB. As a 
control, T cells alone were cultured with serial di- 
lutions of SEB (circles).  IL-2 production was quanti- 
tated from the 24-h culture supernatants. (C) Vari- 
ous  numbers of ~/-irradiated spleen cells from 
control (circles)  or LPS-treated (squares)  mice were 
cultured with 3 ￿  104 T  cell hybridoma 13-26-8 
and  100  p,g/ml sperm whale rnyoglobin, and the 
IL-2 content was evaluated from the 24-h culture 
supernatants. (D) Various numbers of*?-irradiated 
spleen cells from control or LPS-treated mice were 
cultured with 3 ￿  105 T cells from CBA mice in 
the presence of antibodies to CD28 or control anti- 
bodies. 1L-2 production was quantitated from the 
48-h culture supematants. Q, control spleen cells + 
control  mAb; I,  control  spleen cells +  o~CD28 
mAb; i,  LPS-treated spleen cells +  control mAb; 
V, LPS-treated spleen cells + &CD28 mAb. 
and in vivo. In particular, purified DC, pulsed extracorpo- 
really with an antigen, induce specific cellular and humoral 
responses  when  injected  into  syngeneic  animals  (22,  23). 
The adjuvant properties of these cultured DC may depend 
on a process of maturation that occurs "spontaneously" in 
vitro during the purification steps (26-30). Whether a sim- 
ilar maturation occurs in vivo is still unknown,  and it is of 
major interest to define the conditions that are required for 
the  induction  of primary responses in  situ.  The  data pre- 
sented herein strongly suggest that LPS induces splenic DC 
maturation in situ, as assessed by upregulation of immuno- 
stimulatory properties and  downmodulation  of processing 
capacity.  These  functional  changes  correlate with  a  rapid 
migration of DC  to T  cell areas,  and  are followed by the 
loss of most splenic DC 48 h  after LPS injection. 
The identification of a specific costimulatory signal such 
as CD28  has focused attention on the functional heteroge- 
neity of APCs.  Indeed, optimal activation of naive T  cells 
requires TCP,. occupancy by antigen/MHC complexes and 
additional signal(s), such as CDS0,  CD86,  CD40,  etc. The 
expression  of  CD80  and  CD86  varies  among  the  APC 
populations and seems to correlate with their immunostim- 
ulatory  properties.  DC  appear  to  have  some  constitutive 
costimulatory function in several sites in situ, but more typ- 
ically, this function rapidly develops upon in vitro culture 
(26).  Steinman's  group  has  defined  two  populations  of 
splenic DC  that differ by their localization and phenotype. 
DC  in the T  cell regions express MHC  class II and B7-2, 
and are recognized by M342 and NLDC-145 mAbs. DC in 
the marginal zone are M342-  and resemble freshly isolated 
DC that become M342 + upon culture. These authors sug- 
gest  that  DC  from  the  marginal  zone  may  give  rise  to 
M342 + ceils in T  cell areas, and this hypothesis is supported 
by our  data showing  that  DC  migrate  from  the  marginal 
zone  to  the  T  cell  area  and  concomitantly  mature  into 
M342 +,  NLDC-145 +  potent  accessory  cells  that  express 
increased levels of class II, B7-1,  and B7-2 molecules. We 
interpret  the  redistribution  of  the  N418  marker  in  the 
spleen 6  h  after LPS  injection as a  migration of DC  from 
the  marginal zone  to  T  cell area,  although  it could result 
from the loss of a subset of DC  present in peripheral areas 
in spleens and from the recruitment of a  distinct subset in 
the  central white  pulp.  Our  hypothesis,  however,  is  sup- 
ported by  the  observatiori  " that  N418 §  cells are  gradually 
detected in regions located from the periphery to the cen- 
ter of the white pulp  1.5-4 h  after LPS injection (data not 
shown).  The  phenotypic changes  observed 6  h  after LPS 
injection correlate with increased stimulatory properties, as 
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Figure  6.  Injection of LPS  results  in impaired DC 
function in vivo after 48 h. BALB/c mice injected  48 h 
previously with NaCI or 25 Ixg LPS were stimulated  by 
an  intravenous injection  of 50  p,g  SEB  or anti-CD3 
mAb. 2  h  later,  the sera were assayed individually  for 
IL-2 and  IFN-~/  production, as described  in Materials 
and  Methods.  Each  bar  represents  the  mean  -+  SD. 
Similar results were obtained in three experiments. The 
groups (') are significantly  different  from control (Stu- 
dent's t test,  P <0.05, n =  5). [], Control; m, LPS 2 d. 
assessed  by enhanced  capacity to induce  IL-2 secretion by 
naive T  ceils  in the presence of SEB.  By contrast,  the  ca- 
pacity of DC to process native protein such as insulin dimin- 
ishes after LPS injection,  as shown by a decreased ability to 
trigger IL-2 production by an insulin-specific T  cell hybri- 
doma. Collectively, these data strongly suggest that imma- 
ture DC present in the marginal zone mature after migra- 
tion to T  cell area. 
It is noteworthy that recent studies (45) have shown that 
the NLDC-145 mAb recognizes a receptor, termed DEC- 
205,  with  a  multilectin  domain  structure  that  favors effi- 
cient capture and presentation of carbohydrate-bearing an- 
tigens. The observation that mature DC lose their capacity 
to  process  antigens  but  display  increased  expression  of 
DEC-205 is intriguing and suggests that DC maintain their 
capacity to selectively bind carbohydrates. Since these com- 
mon constituents of microbial cell walls have structures that 
are distinct  from those  of carbohydrates of eukaryotic cell 
surfaces, mature DC may discriminate self from infectious 
nonself. 
The loss  of splenic DC 2  d  after endotoxin  administra- 
tion probably reflects a physical disappearance of these cells 
rather  than  downmodulation  of DC-specific  markers,  as 
suggested by the loss of several molecules (class II, CDllc, 
NLDC-145,  and  M342),  the  movement  of N418 §  cells 
early after injection, and the corresponding functional defi- 
ciency.  In vitro,  we showed  that  the  capacity to  sensitize 
naive T  cells, a unique property of DC, is impaired in mice 
that were injected with LPS 2 d earlier. By contrast, spleen 
cells from treated mice retain the capacity to activate a co- 
stimulatory-independent T  ceil hybridoma, as well as naive 
T  cells  in the presence of an anti-CD28  mAb that mimics 
B7  engagement.  In  vivo,  activation  of T  cells  by  DC- 
dependent T  ceil mitogen (SEB) is impaired in LPS-treated 
mice, as assessed by IL-2 and IFN-~ secretion. By contrast, 
similar levels of both  cytokines are  released in  the  sera of 
mice after the injection ofa DC-independent stimulus such 
as anti-CD3 mAb. These observations strongly suggest that 
the  inability  to  induce  primary responses  in  vitro  and  in 
vivo results  from the  selective loss  of cells  from the  den- 
dritic lineage,  which  displays  some costimulatory function 
in vivo in the absence of intentional stimulation. 
The  disappearance  of DC  could  be  caused  by cell  ex- 
haustion,  migration out of the spleen,  or death  (by induc- 
tion of apoptosis?). Fas ligand and TNF have indeed been 
found to induce  apoptosis in  several cell types (46,  47).  A 
similar loss  of DC was induced by LPS in mice displaying 
defective Fas ligand  (our unpublished  observations), how- 
ever,  suggesting  that  the  induction  of programmed  cell 
death via Fas/FasL is not involved in this phenomenon. Al- 
ternatively, mature DC could migrate from the T  cell area 
to the liver, where they would be eliminated, or to the ce- 
liac nodes, although there is some evidence that DC do not 
recirculate from blood to lymph (48).  It would be of major 
interest to analyze whether this sequence of events is regu- 
lated by DC/T interaction in the presence of antigen.  The 
injection of LPS and the antigen in mice expressing a TCR 
transgene  will  help  to  analyze  whether  antigen-specific, 
MHC-restricted interaction  between  DC  and  T  lympho- 
cytes would lead to reciprocal regulation  of function and, 
in particular, may prevent a rapid loss of DC. 
The loss  of DC after endotoxin administration could be 
related to the marked depression of cell-mediated immune 
functions,  often associated with septic shock.  Indeed,  sev- 
eral lines of evidence suggest that the depression in the pa- 
tient's immune  function  induced  by traumatic  injury  un- 
derlies the development of infection and/or sepsis (49-51). 
The  analysis  of DC  phenotype  and  function  in  these  pa- 
tients would help to evaluate the role of DC in the patho- 
genesis of sepsis. 
Our data  extend previous studies  showing that  LPS af- 
fects DC populations. Groeneveld and co-workers showed 
that  the  number  of interdigitating  cells  was  severely  de- 
creased  in  the  mouse  48  h  after LPS  administration  (52). 
More recently, MacPherson et al. reported that injection of 
LPS in rats caused an increased release of intestinal DC into 
lymph  (53).  Similarly, Austyn's group  showed  that  injec- 
tion of LPS induced a loss  of DC from the heart, kidneys, 
and epidermal Langerhans cells (54). By contrast, LPS aero- 
solized has been shown to recruit DC into the conducting 
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matory cytokines  or exogenous bacterial products  modu- 
late the cell-surface phenotype and the immunostimulatory 
function of human cultured DC (56). 
Migration patterns  of DC in the mouse have been ex- 
tensively studied.  Skin painting mice with picryl chloride 
resulted  in  an  increase  in  the  number  of DC  in  lymph 
nodes  that  initiate  primary antigen-specific stimulation  in 
vitro  and  in  vivo  (57).  Donor-derived  DC  have  been 
shown to move from the nonlymphoid organs to the recip- 
ient's spleen, where they trigger allograft rejection (20). La- 
beled mature DC transferred intravenously into a syngeneic 
host localized in the spleen and the homing was T  depen- 
dent (58).  After subcutaneous footpad inoculation, DC ac- 
cumulated  in  the  popliteal  nodes  (48).  These  data  show 
that DC migrate from nonlymphoid tissues  to T  cell areas 
of lymphoid organs,  and  our results suggest that  this  flux 
may correlate with a functional maturation. 
A  large array of cytokines and/or  inflammatory media- 
tors (including TNF-ot, IL-1[3, IL-6, IL-12, and GM-CSF) 
is secreted in mice after LPS injection. We have tested the 
effect of two cytokines that have been shown to affect DC 
viability and/or maturation in vitro or in vivo (59-61). The 
injection of recombinant TNF-o~ induced migration of DC 
to the T  cell area, followed by loss  of these cells,  whereas 
GM-CSF did not affect the DC population (De Smedt, T., 
and M.  Moser,  manuscript in preparation).  Simultaneous 
injection of neutralizing anti-TNF-or  mAb and LPS, how- 
ever, did not prevent DC movement, suggesting that ad- 
ditional  factors induced by LPS may promote DC migra- 
tion  in vivo. Experiments  are in progress to test whether 
IL-1,  which  has  been  shown  to  induce  changes  in  DC 
function in vitro  (62)  and promote DC migration in vivo 
(59),  is involved in this phenomenon. 
A direct effect of endotoxin on DC cannot be excluded, 
however, since treatment of DC by LPS has been shown to 
lead  to  increased  expression  of  IL-1,  IL-6,  and  IL-12 
mRNA  by these  cells  (63),  as well as  to  upregulate  gene 
expression and induce release of TNF-oL in DC clones (64). 
The cell population(s) involved in this phenomenon re- 
main(s)  to  be  identified.  The  injection  of LPS  in  SCID 
mice  results  in  similar  changes  in  DC  (data  not  shown), 
suggesting that functional T  and B lymphocytes are not re- 
quired for this phenomenon. 
LPS  endotoxin  from  Gram-negative bacteria  possesses 
both harmful and beneficial effects. LPS triggers a host im- 
mune response resulting in activation of various cell types 
and  production  of multiple  cytokines  that  mediate  resis- 
tance  to  the  bacteria.  An  exaggerated  inflammatory  re- 
sponse to bacterial products, however, may cause irrevers- 
ible  tissue  damage  leading  to  death  when  homeostasis  is 
disrupted. Therefore, it is tempting to speculate that the in- 
hibition of DC function in endotoxemia may constitute a 
feedback aimed at maintaining the homeostasis of the im- 
mune system by inhibiting  the  function  of the  most effi- 
cient APC in vivo. Such a mechanism would be beneficial 
to the host by preventing harmful effects of an exaggerated 
inflammatory response, as well as to the bacteria, by limit- 
ing the pathogen-specific immune response. The selective 
loss  of DC  after  endotoxin  administration  may  provide 
some insights in bacterial-host relations,  and in particular, 
suggest that bacteria may derive some evolutionary advan- 
tage to retain a wall component that is strongly immuno- 
genic, since high doses of LPS may reduce host resistance 
to the spread of bacteria. 
In  conclusion,  our  data  support  the  hypothesis  that  a 
critical signal for the initiation of immune responses is pro- 
vided by microbial infection, as proposed by Janeway (65). 
LPS induces costimulatory activity for CD4 + T  cells  on B 
lymphocytes and  macrophages  (66),  and  triggers  matura- 
tion and migration of DC in vivo (this paper). The upregu- 
lation of DC function by microbial products and their sub- 
sequent movement to T  cell areas result in colocalization of 
T  lymphocytes and mature DC that have encountered mi- 
crobial antigens.  Since immature DC have been shown to 
take up and process antigen, a property that can be lost in 
mature DC, it is tempting to speculate that most DC in 
T  cell  areas  would  present  infectious  non-self-antigens. 
The  positive and negative regulation  of antigen  presenta- 
tion by microbial agents may help to gain an understanding 
of how the immune system efficiently eliminates pathogens 
while avoiding self-reactivity and controls potentially harm- 
ful inflammatory responses. 
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